NFKB1 and COVID-19: Shufeng Jiedu capsule can increase the expression of the A2A adenosine receptor, inhibit NF-κB phosphorylation, reduce inflammation and inhibit apoptosis and ultimately improve acute lung injury in COVID-19 (180).